Nurse Practitioner, Family · Knoxville, TN
NPI
1972997005
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4713 Papermill Dr, Suite 300
Knoxville, TN, 37909
Phone (865) 454-8979
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
1,481 services
Medicare patients, 2024
345
Average age 75
Drug cost, 2024
$195K
1,406 prescriptions
Company payments, 2025
$1,870
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diane M Reber was code 99213 (office e&m - established), 321 times for 175 patients. In total Diane M Reber billed 1,481 services in 33 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 321 | 175 | $54.14 | $17K |
| 81002 Clinical Chemistry | Office | 320 | 182 | $3.25 | $1,041 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 166 | 144 | $63.53 | $11K |
| 51798 Ultrasound - Nonspecific | Office | 100 | 83 | $7.55 | $755 |
| 99214 Office E&M - Established | Office | 71 | 56 | $77.34 | $5,491 |
| 99212 Office E&M - Established | Office | 51 | 14 | $35.50 | $1,810 |
| 51700 Other Organ Systems | Office | 19 | 12 | $44.88 | $853 |
| 99204 Office E&M - New | Office | 16 | 16 | $106.82 | $1,709 |
| 96372 Injection Administration | Office | 14 | 12 | $8.23 | $115 |
| 64561 Neurostimulator - Back | Office | 12 | 12 | $651.77 | $7,821 |
| 76872 Ultrasound - Nonspecific | Office | 11 | 11 | $82.57 | $908 |
By year: 2022 $72K for 2,945 services; 2023 $63K for 2,401 services; 2024 $56K for 1,481 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 320 | 182 | $3.25 | $1,041 |
Medicare prescription drug claims, 2024
In 2024, the drug Diane M Reber prescribed most often to Medicare patients was Tamsulosin Hcl, with 126 prescriptions and refills. In total Diane M Reber wrote 1,406 Medicare prescriptions that cost $195K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 126 | 308 | 52 | $1,324 |
| Fluconazole Generic | 95 | 95 | 55 | $880 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 75 | 90 | 50 | $314 |
| Ciprofloxacin Hcl Generic | 68 | 72 | 50 | $554 |
| Oxybutynin Chloride Generic | 66 | 106 | 24 | $968 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 64 | 83 | 41 | $1,451 |
| Estradiol Generic | 52 | 110 | 28 | $3,123 |
| Nystatin Generic | 50 | 52 | 29 | $670 |
| Myrbetriq Mirabegron | 47 | 87 | 16 | $38K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 47 | 99 | 22 | $745 |
| Minocycline Hcl Generic | 38 | 51 | Under 11 | $509 |
| Gemtesa Vibegron | 37 | 79 | 11 | $37K |
| Finasteride Generic | 36 | 88 | 16 | $617 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 33 | 62 | 14 | $893 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 29 | 29 | 17 | $107 |
Brand drugs: - claims; generic drugs: 1,254 claims; opioid claims: 60.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diane M Reber $1,870 ($1,870 in general payments such as food, travel and fees) from 28 companies. The largest payer was C. R. Bard, Inc. & Subsidiaries with $387.
| Company | Payments | Amount |
|---|---|---|
| C. R. Bard, Inc. & Subsidiaries BDX | 15 | $387 |
| Sumitomo Pharma America, Inc. 4506.T | 13 | $272 |
| Teleflex LLC TFX | 1 | $133 |
| Endo USA, Inc. | 7 | $117 |
| Abbvie Inc. ABBV | 4 | $101 |
| Dendreon Pharmaceuticals LLC | 2 | $85.57 |
| Astellas Pharma US Inc 4503.T | 3 | $79.45 |
| Immunitybio, Inc. IBRX | 3 | $65.6 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $65.38 |
| Coloplast Corp | 4 | $62.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.